Stereotaxis received clearance from the Food & Drug Administration for its latest surgical robotic system, GenesisX. The maker of surgical robots on Monday said the GenesisX builds upon the benefits ...
Learn about the IRS’s new Code Y for reporting Qualified Charitable Distributions (QCDs) from IRAs, effective in 2025.
Stereotaxis (NYSE:STXS) announced today that it received FDA 510(k) clearance for its next-generation GenesisX surgical robot.
On Nov. 5, 2025, CMS finalized a rule that fundamentally changes Medicare payment methodology for a broad range of skin substitute products used for wound care. Beginning in January 2026, most skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback